Solar Pharma deal structurally sturdy, debt the one overhang: Amit Khurana
Chatting with ET Now, market knowledgeable Amit Khurana from Dolat Capital provided a measured take—highlighting alternative, however not with out warning.
Solar Pharma’s Large Wager: Strategic Match, Debt a Watchpoint
Solar Pharma’s all-cash acquisition, priced at $14 per share, has drawn consideration for each its scale and strategic intent. Khurana acknowledged the inherent issue in judging whether or not the worth is “proper,” noting that execution will finally decide success.
“Properly, sure, I imply that’s at all times the robust one to reply as a result of finally the combination points, the entire synergies and the positioning over a time frame will decide whether or not this was a good value or not.”
He identified that the acquisition strengthens Solar Pharma’s portfolio, notably in biosimilars, whereas additionally opening room for operational enhancements.
“However on the face of it, it does seem like a fairly fairly properly justified acquisition on what it provides to the portfolio for Solar Pharma, particularly on the biosimilars entrance and in addition on the opposite facet Organon didn’t have that a lot of R&D and subsequently Solar’s functionality will add to their capability to ramp up the merchandise. Fairness valuation appears fairly affordable.”
Nevertheless, the deal’s almost $10 billion debt part stays a key concern. “Slight concern if one have been to focus on is extra on the debt facet of it and the way will that basically get addressed, that will likely be one type of joker within the pack that the administration should navigate very-very rigorously and the markets will most likely take a cue on that.”
Nonetheless, Khurana maintained that the transfer is directionally sound.
“However total, fairly good structurally and strategically an excellent acquisition for an Indian entity and Solar has been looking out for such buyouts to scale up the enterprise over a long run. So directionally, sure, the best transfer. The debt is the one type of caveat. In any other case, we’re in fine condition total.”
Is the Debt Manageable?
Regardless of the dimensions of the borrowing, Khurana doesn’t see it as alarming—offered execution stays on observe.
“Based mostly on what the administration is guiding appears manageable.”
He emphasised that integration velocity and product scalability will likely be vital in figuring out how comfortably the corporate handles its obligations.
“Now Solar’s functionality to scale it up additional over the subsequent few years would be the giant determinant of how the money flows work out after which, after all, you have got the general market atmosphere which if it doesn’t deteriorate then clearly there will likely be numerous assist on that entrance. So, I’d say largely manageable. It’s not as if it’s a scenario of a SOS, but it surely should be navigated very rigorously.”
Paytm Funds Financial institution: Restricted Injury to the Core Story
On the regulatory entrance, the cancellation of Reserve Financial institution of India license for Paytm Funds Financial institution raised issues. Nevertheless, Khurana downplayed its long-term affect on Paytm’s listed entity.
“Properly, small affect right here or there, however I don’t assume it actually makes a change in our view on the inventory per se.”
He highlighted that Paytm’s core enterprise fundamentals stay intact.
“In our view, the general core enterprise profitability appears to be just about on observe and the scalability is admittedly taking part in out and, after all, over the previous few quarters we now have seen a big value management measures which have been taking part in out on Paytm and that can proceed to be the motive force in our view.”
Whereas sentiment could take a short-term hit, the broader outlook stays unchanged.
“There may be perhaps a small damper, however I don’t assume it modifications the longer-term story in any method.”
Banking Sector: Steady, With Upside Potential
Turning to the banking area, Khurana famous a broadly secure earnings season with no main surprises.
“No vital deviation that so far as we now have seen within the earnings season until date. A lot of the vectors are declaring in direction of a requirement for credit score.”
Nevertheless, world uncertainties—notably geopolitical tensions—are prompting warning.
“There’s a type of a, shall I say, guarded view, a cautious view on as to how the affect of the US-Iran battle will play out on company stability sheets.”
Even so, he stays constructive on the sector.
“General numbers look fairly wholesome. The valuations have corrected very fairly throughout the board and subsequently that provides numerous consolation… I feel banking at giant will proceed to be in a fine condition and subsequently our view is barely extra constructive than what was the case six months again.”
Amongst large-cap lenders, ICICI Financial institution stands out as a most popular decide.
NBFCs vs Banks: A Shift in Choice
Khurana struck a extra cautious tone on NBFCs, citing stretched valuations in segments like gold and auto financing.
“So, I’d most likely put it extra within the impartial zone proper now on total NBFC area.”
As an alternative, he favors banks as a result of higher risk-reward dynamics.
“The truth is, I’d most likely choose banks from right here on versus the NBFC area given the valuations being way more engaging and the danger return profile being way more engaging.”
The place Is the Alternative Now?
Trying past the sectors mentioned, Khurana stays centered on India’s consumption story.
“We’re taking part in to the… and basically needed to play out on the consumption theme in India largely and discretionary consumption which stays one in all our favorite themes.”
He additionally highlighted selective, bottom-up alternatives fairly than broad sector bets. Amongst them:
He additionally pointed to stronger curiosity in home web themes and defence-related performs.
The Backside Line
From a blockbuster pharma deal to regulatory shocks and sectoral shifts, Khurana’s outlook displays cautious optimism. Whereas dangers—from debt to geopolitics—stay, the underlying tone is obvious: India’s structural progress story, notably in consumption and banking, continues to carry agency.
